Cargando…
Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study
INTRODUCTION: Glycemic variability (GV) represents the amplitude of oscillations in glucose levels over time and is associated with higher mortality in critically ill patients. Our aim is to evaluate the impact of GV on acute ischemic stroke (IS) outcomes in humans and explore the impact of two diff...
Autores principales: | Fuentes, Blanca, Pastor-Yborra, Silvia, Gutiérrez-Zúñiga, Raquel, González-Pérez de Villar, Noemí, de Celis, Elena, Rodríguez-Pardo, Jorge, Gómez-de Frutos, Mari Carmen, Laso-García, Fernando, Gutiérrez-Fernández, María, Ortega-Casarrubios, MÁngeles, Soto, Alfonso, López-Fernández, María, Santamaría, María, Díez-González, Noemí, Freijo, Mar M., Zandio, Beatriz, Delgado-Mederos, Raquel, Calleja, Ana, Portilla-Cuenca, Juan Carlos, Lisbona, Arturo, Otero-Ortega, Laura, Díez-Tejedor, Exuperio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610240/ https://www.ncbi.nlm.nih.gov/pubmed/33148277 http://dx.doi.org/10.1186/s12967-020-02586-4 |
Ejemplares similares
-
Recovery After Stroke: New Insight to Promote Brain Plasticity
por: Otero-Ortega, Laura, et al.
Publicado: (2021) -
Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial
por: de Celis-Ruiz, Elena, et al.
Publicado: (2022) -
White Matter Repair After Extracellular Vesicles Administration in an Experimental Animal Model of Subcortical Stroke
por: Otero-Ortega, Laura, et al.
Publicado: (2017) -
NogoA Neutralization Promotes Axonal Restoration After White Matter Injury In Subcortical Stroke
por: Otero-Ortega, Laura, et al.
Publicado: (2017) -
Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research
por: Laso-García, Fernando, et al.
Publicado: (2019)